| Financial Year |
March 31 2023 |
| Monetary Funds |
131,818,309.89 |
| Held-for-trading Financial Assets |
39,711.63 |
| Notes Receivable |
98,714,946.43 |
| Accounts Receivable |
456,660,976.12 |
| Advances to Suppliers |
21,879,524.38 |
| Other Receivables |
18,581,701.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
266,445,879.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,788,692.28 |
| Total Current Assets |
1,201,593,752.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
46,634,999.85 |
| Investment Properties |
20,229,996.86 |
| Fixed Assetes |
334,316,124.40 |
| Under-construction Projects |
132,138,956.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
127,745,284.07 |
| R&D expenses |
-- |
| Goodwill |
47,825,998.28 |
| Long-Term Deferred and Prepaid Expenses |
35,261,920.15 |
| Deferred Income Tax Assets |
14,001,509.53 |
| Other Non-Current Assets |
20,363,827.70 |
| Sub-Total of Non-Current Assets |
791,290,996.22 |
| Total Assets |
1,992,884,748.24 |
| Short-Term Loans |
327,756,294.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
174,436,474.39 |
| Accounts Payable |
425,090,614.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,179,764.52 |
| Taxes Payable |
11,850,091.91 |
| Interest Payable |
-- |
| Dividend Payable |
9,478,741.88 |
| Other payables |
74,849,634.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,761,062.93 |
| Other Current Liabilities |
99,214,956.03 |
| Sub-Total of Current Liabilities |
1,204,960,277.06 |
| Long-term Loans |
2,040,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,963,257.46 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,236,748.10 |
| Deferred Income Tax Liabilities |
1,573,902.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
48,686,936.41 |
| Total Liabilities |
1,253,647,213.47 |
| Paid-In Capital(Or Share Stock) |
401,000,000.00 |
| Capital Surplus |
807,937,615.62 |
| Surplus Reserve |
31,350,119.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-544,940,634.89 |
| Minority Stockholder's Interest |
43,890,434.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
695,347,100.13 |
| Owner's Equity（Stockholder's Equity） |
739,237,534.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,992,884,748.24 |
